ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

AZTR Azitra Inc

0,1461
0,0009 (0,62%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Azitra Inc AZTR AMEX Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,0009 0,62% 0,1461 00:58:29
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,1408 0,1408 0,154 0,1493 0,1452
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/6/202422:30EDGAR2Form DEF 14A - Other definitive proxy statements
31/5/202414:00BWAzitra, Inc. Announces Presentation at the 2024 BIO..
24/5/202422:55EDGAR2Form PRE 14A - Other preliminary proxy statements
17/5/202414:00BWAzitra, Inc. Announces Positive Preclinical Data from ATR-04..
10/5/202414:00BWAzitra, Inc. Announces Positive Preclinical Data of ATR-12..
09/5/202423:05EDGAR2Form 8-K - Current report
09/5/202423:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202423:00BWAzitra, Inc. Announces Q1 2024 Financial Results and..
22/4/202422:30BWAzitra, Inc. Announces New Preclinical Data to be Presented..
18/4/202422:15BWAzitra, Inc. to Present New Data at Three Upcoming..
15/3/202421:15BWAzitra, Inc. Announces Full Year 2023 Financial Results and..
26/2/202422:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/2/202422:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
16/2/202422:05BWAzitra, Inc. Announces Closing of Public Offering
16/2/202402:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202415:15EDGAR2Form 8-K - Current report
14/2/202404:09BWAzitra, Inc. Announces Pricing of Public Offering
19/1/202417:08EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
19/1/202415:19EDGAR2Form S-1 - General form for registration of securities under..
16/1/202415:00BWAzitra, Inc. Strengthens Intellectual Property Portfolio..
03/1/202415:00BWAzitra, Inc. to Present at Biotech Showcase 2024 and the..
04/12/202322:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202322:30BWAzitra, Inc. Announces Third Quarter 2023 Financial Results..
16/10/202314:00BWAzitra to Present at the ThinkEquity Conference
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202314:00PRNUSAzitra to Present at the H.C. Wainwright 25th Annual Global..
14/8/202322:11EDGAR2Form 8-K - Current report
14/8/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:05PRNUSAzitra, Inc. Announces Second Quarter 2023 Financial Results..
19/7/202322:05PRNUSAzitra Adds Biotech Leaders Barbara Ryan and John Schroer to..
11/7/202322:05EDGAR2Form 8-K - Current report
11/7/202322:05PRNUSAzitra, Inc. Appoints Travis Whitfill as Chief Operating..
07/7/202322:05EDGAR2Form 8-K - Current report
03/7/202321:04EDGAR2Form SC 13D - General statement of acquisition of beneficial..
29/6/202322:56EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
22/6/202300:46PRNUSAzitra, Inc. Announces Closing of Initial Public Offering

Dernières Valeurs Consultées